Summary

Report Scope
This brief report offers an overview of the global gene transfer technologies market and examines market trends. It includes worldwide revenue (in millions of dollars) for the base year 2025 and forecast data from 2026 to 2031. The market is segmented by delivery methods/mode into viral vectors, non-viral vectors, and physical techniques. Physical methods are sub-segmented into electroporation, gene guns, and microinjection. Based on application, the market segments include gene therapy, cell therapy, vaccines, and research. The regions analyzed in this study are North America, Europe, Asia-Pacific, and the Rest of the World.
The report focuses on key trends, challenges, and technological advances shaping the market and vendor landscape. The report concludes with an analysis of the competitive landscape of prominent companies in the global gene transfer technologies market. It also has a dedicated section of company profiles that covers details such as overview, product portfolio, and strategic developments of key companies in the market.
Report Includes
- An overview and analysis of the global market for gene transfer technologies
- Analyses of global market trends, with revenue data for 2025, estimates for 2026, and projections of CAGRs through 2031 (in $ Millions)
- Estimates of the current market size and revenue growth prospects for the global market, along with a market share analysis by mode, application and region
- Facts and figures related to market dynamics, including drivers, restraints and opportunities influencing the market
- Discussion of emerging technologies and developments in gene transfer technologies
- Competitive intelligence, including strategic analysis of key companies operating in the market
- Profiles of leading companies in the global gene transfer technologies market

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Market Definition
Technology Background
Viral Vector Gene Delivery Systems
Non-viral Vector Gene Delivery Systems
Physical Methods
PESTEL Analysis
Impact of U.S. Tariff Laws on the Gene Transfer Technologies Market
Effects on Supply Chain
Opportunities for Local Production
Conclusion
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Growing Cell and Gene Therapy Market
Rising Prevalence of Chronic Diseases
Market Restraints
Lack of Skilled Workforce
Production Scalability Issues
Market Opportunities
Advances in Gene Editing Technologies
Increasing Collaborations and Partnerships
Chapter 4 Emerging Technologies and Developments
Overview
CRISPR/ Cas9 Genome Editing
Artificial Intelligence in Gene Transfer Technology
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Breakdown by Mode
Key Takeaways
Viral Vectors
Non-viral Vectors
Physical Methods
Market Breakdown by Application
Key Takeaways
Gene Therapy
Research
Cell Therapy
Vaccines
Geographic Breakdown
Market Breakdown by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Key Takeaways
Leading Companies in the Gene Transfer Technologies Market
Strategic Analysis
Key Strategies of Prominent Companies in the Gene Transfer Technologies Market
Chapter 7 Appendix
Methodology
Abbreviations
References
Company Profiles
4D MOLECULAR THERAPEUTICS
BIO-RAD LABORATORIES INC.
CREATIVE BIOLABS
LONZA
MAXCYTE
MERCK KGAA
OXFORD BIOMEDICA PLC
QIAGEN
SARTORIUS AG
THERMO FISHER SCIENTIFIC INC.

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Gene Transfer Technologies, by Region, Through 2031
Table 1 : Key Research Collaborations and Partnerships
Table 2 : Global Market for Gene Transfer Technologies, by Mode, Through 2031
Table 3 : Viral Vectors in Gene Therapy Products
Table 4 : Approved Viral Vector-based Gene Therapy Products
Table 5 : Global Market for Gene Transfer Technologies for Viral Vectors, by Region, Through 2031
Table 6 : Global Market for Gene Transfer Technologies for Non-Viral Vectors, by Region, Through 2031
Table 7 : Global Market for Gene Transfer Technologies for Physical Methods, by Region, Through 2031
Table 8 : Global Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 9 : Global Market for Gene Transfer Technologies for Electroporation, by Region, Through 2031
Table 10 : Global Market for Gene Transfer Technologies for Microinjection, by Region, Through 2031
Table 11 : Global Market for Gene Transfer Technologies for Gene Gun, by Region,Through 2031
Table 12 : Global Market for Gene Transfer Technologies, by Application, Through 2031
Table 13 : Global Market for Gene Transfer Technologies for Gene Therapy, by Region, Through 2031
Table 14 : Global Market of Gene Transfer Technologies for Research, by Region, Through 2031
Table 15 : Global Market of Gene Transfer Technologies for Cell Therapy, by Region, Through 2031
Table 16 : Global Market of Gene Transfer Technologies for Vaccines, by Region, Through 2031
Table 17 : Global Market for Gene Transfer Technologies, by Region, Through 2031
Table 18 : North American Market for Gene Transfer Technologies, by Mode, Through 2031
Table 19 : North American Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 20 : North American Market for Gene Transfer Technologies, by Application, Through 2031
Table 21 : European Market for Gene Transfer Technologies, by Mode, Through 2031
Table 22 : European Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 23 : European Market for Gene Transfer Technologies, by Application, Through 2031
Table 24 : Asia-Pacific Market for Gene Transfer Technologies, by Mode, Through 2031
Table 25 : Asia-Pacific Market of Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 26 : Asia-Pacific Market for Gene Transfer Technologies, by Application, Through 2031
Table 27 : RoW Market for Gene Transfer Technologies, by Mode, Through 2031
Table 28 : RoW Market for Gene Transfer Technologies for Physical Methods, by Type, Through 2031
Table 29 : RoW Market for Gene Transfer Technologies, by Application, Through 2031
Table 30 : Vector Manufacturing Portfolio of Key Companies in the Gene Transfer Technologies Market
Table 31 : Recent Developments: Gene Transfer Technologies Market, 2023–2026
Table 32 : Abbreviations Used in this Report
Table 33 : 4D Molecular Therapeutics: Company Snapshot
Table 34 : 4D Molecular Therapeutics: Financial Performance, FY 2024 and 2025
Table 35 : 4D Molecular Therapeutics: Product Portfolio
Table 36 : 4D Molecular Therapeutics: News/Key Developments, 2023–2025
Table 37 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 38 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2024 and 2025
Table 39 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 40 : Bio-Rad Laboratories Inc.: News/Key Developments, 2025
Table 41 : Creative Biolabs: Company Snapshot
Table 42 : Creative Biolabs: Product Portfolio
Table 43 : Creative Biolabs: News/Key Developments, 2025–2026
Table 44 : Lonza: Company Snapshot
Table 45 : Lonza: Financial Performance, FY 2024 and 2025
Table 46 : Lonza: Product Portfolio
Table 47 : MaxCyte: Company Snapshot
Table 48 : MaxCyte: Financial Performance, FY 2024 and 2025
Table 49 : MaxCyte: Product Portfolio
Table 50 : MaxCyte: News/Key Developments, 2025–2026
Table 51 : Merck KGaA: Company Snapshot
Table 52 : Merck KGaA: Financial Performance, FY 2024 and 2025
Table 53 : Merck KGaA: Product Portfolio
Table 54 : Merck KGaA: News/Key Developments, 2024
Table 55 : Oxford Biomedica PLC: Company Snapshot
Table 56 : Oxford Biomedica PLC: Financial Performance, FY 2024 and 2025
Table 57 : Oxford Biomedica PLC: Product Portfolio
Table 58 : Oxford Biomedica PLC: News/Key Developments, 2023–2026
Table 59 : Qiagen: Company Snapshot
Table 60 : Qiagen: Financial Performance, FY 2024 and 2025
Table 61 : Qiagen: Product Portfolio
Table 62 : Qiagen: News/Key Developments, 2025
Table 63 : Sartorius AG: Company Snapshot
Table 64 : Sartorius AG: Financial Performance, FY 2024 and 2025
Table 65 : Sartorius AG: Product Portfolio
Table 66 : Sartorius AG: News/Key Developments, 2023–2025
Table 67 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 68 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 69 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 70 : Thermo Fisher Scientific Inc.: News/Key Developments, 2025

List of Figures
Summary Figure : Global Market Shares for Gene Transfer Technologies, by Region, 2025
Figure 1 : PESTEL Analysis: Gene Transfer Technologies Market
Figure 2 : Market Dynamics of Gene Transfer Technologies
Figure 3 : Viral Vector-based Cell and Gene Therapy Clinical Trials
Figure 4 : Investments in Cell and Gene Therapy, by Year
Figure 5 : Global Market Shares for Gene Transfer Technologies, by Mode, 2025
Figure 6 : Global Market Shares for Gene Transfer Technologies for Physical Methods, by Type, 2025
Figure 7 : Global Market Shares for Gene Transfer Technologies, by Application, 2025
Figure 8 : Global Market Shares for Gene Transfer Technologies, by Region, 2025
Figure 9 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 10 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2025
Figure 11 : LONZA: Revenue Shares, by Business Unit, FY 2025
Figure 12 : LONZA: Revenue Shares, by Region, FY 2025
Figure 13 : MAXCYTE: Revenue Shares, by Business Unit, FY 2025
Figure 14 : MAXCYTE: Revenue Shares, by Country/Region, FY 2025
Figure 15 : Merck KGaA: Revenue Shares, by Business Unit, FY 2025
Figure 16 : Merck KGaA: Revenue Shares, by Country/Region, FY 2025
Figure 17 : Oxford Biomedica PLC: Revenue Shares, by Business Unit, FY 2025
Figure 18 : Oxford Biomedica PLC: Revenue Shares, by Country/Region, FY 2025
Figure 19 : QIAGEN: Revenue Shares, by Business Unit, FY 2025
Figure 20 : QIAGEN: Revenue Shares, by Country/Region, FY 2025
Figure 21 : Sartorius AG: Revenue Shares, by Business Unit, FY 2025
Figure 22 : Sartorius AG: Revenue Shares, by Country/Region, FY 2025
Figure 23 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 24 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025